Extraction Technologies for Medicinal and Aromatic ... - Capacity4Dev
Extraction Technologies for Medicinal and Aromatic ... - Capacity4Dev Extraction Technologies for Medicinal and Aromatic ... - Capacity4Dev
13 COUNTER-CURRENT CHROMATOGRAPHY Examples of some important natural products that have been separated using HSCCC-CPC in the recent past are summarized herein. 13.5.2.1 Purification of Coenzyme Q 10 from Fermentation Extract: HSCCC versus Silica Gel Column Chromatography HSCCC was applied to the purifi cation of coenzyme Q 10 (CoQ 10 ) for the fi rst time. CoQ 10 was obtained from a fermentation broth extract. A non-aqueous two-phase solvent system composed of heptane–acetonitrile– di chloro methane (12:7:3.5, v/v/v) was selected by analytical HSCCC and used for purifi cation of CoQ 10 from 500 mg crude extract. The separation yielded 130 mg CoQ 10 at an HPLC purity of over 99%. The results showed the advantages of HSCCC over an alternative of silica gel chromatography followed by recrystallization. These advantages regard purity, recovery and yield (Table 3). Table 3: Purification of coenzyme Q 10 from fermentation extract: HSCCC vs. silica gel column chromatography with subsequent crystallization Crude extract CoQ 10 purified by silica gel chromatography HPLC purity, % 89.2 96.0 99.2 Absolute purity, % 29.4 93.3 97.8 Recovery, % * – 74.3 88.0 Yield, % * – 23.4 26.4 CoQ 10 purified by HSCCC * Recovery, amount of CoQ 10 in purifi ed product/amount of CoQ 10 in crude extract. Yield,amount of purifi ed product/amount of crude extract (Journal of Chromatography A 1127 (1-2), 15 September 2006, 92-96) 13.5.2.2 Preparative Separation of Gambogic Acid and its C-2 Epimer by HPCCC For the preparative separation of epimers, gambogic acid and epigambogic acid, from Garcinia hanburyi, a two-phase solvent system composed of n-hexane–methanol–water (5:4:1, v/v/v) was used. From 50 mg mixture, 28.2 mg gambogic acid and 18.4 mg epigambogic acid were separated. The purities of both were above 97% as determined by HPLC. The chemical structures were then identified by their 1 H NMR and 13 C NMR spectra. 13.5.2.3 Separation and Purification of 10-deacetylbaccatin III by HSCCC At present, the most promising approach is the semisynthesis of paclitaxel or its analogs from 10-deacetylbaccatin III, a compound available in a relatively high quantity from the foliage of several yew species. HSCCC was used for the separation and purification of 10-deacetylbaccatin III (Figure 11). A crude needle extract (500 mg/5 ml) from Chinese yew (Taxus chinensis) was 228
EXTRACTION TECHNOLOGIES FOR MEDICINAL AND AROMATIC PLANTS first separated with a two-phase solvent system composed of n-hexane–ethyl acetate–ethanol–water (2:5:2:5, v/v). The partially purified fraction was again purified with a different solvent system composed of n-hexane–chloroform– methanol–water (5:25:34:20, v/v). HPLC analysis of the final fraction showed that the purity of 10-deacetylbaccatin (20 mg) was over 98%. Figure 11: Separation and purifi cation of 10-deacetylbaccatin III (DAB) by HSCCC 229
- Page 181 and 182: EXTRACTION TECHNOLOGIES FOR MEDICIN
- Page 183 and 184: EXTRACTION TECHNOLOGIES FOR MEDICIN
- Page 185 and 186: EXTRACTION TECHNOLOGIES FOR MEDICIN
- Page 187 and 188: EXTRACTION TECHNOLOGIES FOR MEDICIN
- Page 189 and 190: EXTRACTION TECHNOLOGIES FOR MEDICIN
- Page 191 and 192: EXTRACTION TECHNOLOGIES FOR MEDICIN
- Page 193 and 194: EXTRACTION TECHNOLOGIES FOR MEDICIN
- Page 195 and 196: EXTRACTION TECHNOLOGIES FOR MEDICIN
- Page 197: EXTRACTION TECHNOLOGIES FOR MEDICIN
- Page 200 and 201: 12 FLASH CHROMATOGRAPHY AND LOW PRE
- Page 202 and 203: 12 FLASH CHROMATOGRAPHY AND LOW PRE
- Page 204 and 205: 12 FLASH CHROMATOGRAPHY AND LOW PRE
- Page 206 and 207: 12 FLASH CHROMATOGRAPHY AND LOW PRE
- Page 208 and 209: 12 FLASH CHROMATOGRAPHY AND LOW PRE
- Page 210 and 211: 12 FLASH CHROMATOGRAPHY AND LOW PRE
- Page 212 and 213: 12 FLASH CHROMATOGRAPHY AND LOW PRE
- Page 214 and 215: 13 COUNTER-CURRENT CHROMATOGRAPHY C
- Page 216 and 217: 13 COUNTER-CURRENT CHROMATOGRAPHY K
- Page 218 and 219: 13 COUNTER-CURRENT CHROMATOGRAPHY 1
- Page 220 and 221: 13 COUNTER-CURRENT CHROMATOGRAPHY a
- Page 222 and 223: 13 COUNTER-CURRENT CHROMATOGRAPHY 1
- Page 224 and 225: 13 COUNTER-CURRENT CHROMATOGRAPHY W
- Page 226 and 227: 13 COUNTER-CURRENT CHROMATOGRAPHY S
- Page 228 and 229: 13 COUNTER-CURRENT CHROMATOGRAPHY 1
- Page 230 and 231: 13 COUNTER-CURRENT CHROMATOGRAPHY
- Page 234 and 235: 13 COUNTER-CURRENT CHROMATOGRAPHY 1
- Page 236 and 237: 13 COUNTER-CURRENT CHROMATOGRAPHY F
- Page 238 and 239: 13 COUNTER-CURRENT CHROMATOGRAPHY 1
- Page 240 and 241: 13 COUNTER-CURRENT CHROMATOGRAPHY H
- Page 243 and 244: EXTRACTION TECHNOLOGIES FOR MEDICIN
- Page 245 and 246: EXTRACTION TECHNOLOGIES FOR MEDICIN
- Page 247 and 248: EXTRACTION TECHNOLOGIES FOR MEDICIN
- Page 249 and 250: EXTRACTION TECHNOLOGIES FOR MEDICIN
- Page 251 and 252: EXTRACTION TECHNOLOGIES FOR MEDICIN
- Page 253 and 254: EXTRACTION TECHNOLOGIES FOR MEDICIN
- Page 255 and 256: EXTRACTION TECHNOLOGIES FOR MEDICIN
- Page 257 and 258: EXTRACTION TECHNOLOGIES FOR MEDICIN
- Page 259 and 260: EXTRACTION TECHNOLOGIES FOR MEDICIN
- Page 261 and 262: EXTRACTION TECHNOLOGIES FOR MEDICIN
- Page 263 and 264: EXTRACTION TECHNOLOGIES FOR MEDICIN
EXTRACTION TECHNOLOGIES FOR MEDICINAL AND AROMATIC PLANTS<br />
first separated with a two-phase solvent system composed of n-hexane–ethyl<br />
acetate–ethanol–water (2:5:2:5, v/v). The partially purified fraction was again<br />
purified with a different solvent system composed of n-hexane–chloro<strong>for</strong>m–<br />
methanol–water (5:25:34:20, v/v). HPLC analysis of the final fraction showed<br />
that the purity of 10-deacetylbaccatin (20 mg) was over 98%.<br />
Figure 11: Separation <strong>and</strong> purifi cation of 10-deacetylbaccatin III (DAB) by HSCCC<br />
229